<DOC>
	<DOCNO>NCT02882373</DOCNO>
	<brief_summary>The goal clinical research study learn L-arginine help control side effect anti-cancer drug high blood pressure , protein urine , kidney problem . L-arginine nutritional supplement compare placebo study . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>L-Arginine For Anti- Vascular Endothelial Growth Factor ( VEGF ) Induced Kidney Injury</brief_title>
	<detailed_description>Study Groups : Participant randomly assign ( flip coin ) 1 2 study group . This do one know one study group well , , bad group . - If participant Group 1 , receive L-arginine . - If participant Group 2 , receive placebo . Study Drug/Placebo Administration : Participant receive L-arginine placebo liquid 4 time day meal . The liquid prepare pharmacy . Participant take study drug/placebo 30 minute meal ( breakfast , lunch , dinner ) around 9 PM . The dose L-Arginine placebo may increase study doctor think need . Study Visits : One ( 1 ) time week participant blood pressure check . This do home participant blood pressure monitor . The study staff teach participant take blood pressure accurately . If participant blood pressure machine , need come clinic 1 time week study . One ( 1 ) time month blood ( Â½ teaspoon ) urine collect protein test check participant 's kidney function . Length Study Participation : Participant may continue take study drug/placebo 3 month . Participant longer able take study drug/placebo symptom get bad , intolerable side effect occur , unable follow study direction . Patient 's participation study follow-up call . Follow-Up Call : One ( 1 ) month participant stop take part study , call study staff ask . This call last 5 minute . This investigational study . L-arginine FDA-approved treatment specific disease condition . Its use study investigational . The study doctor explain study drug design work . Up 40 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<criteria>1 . On enrolled antiVEGF therapy 2 . Systolic Blood Pressure &gt; = 140 mm Hg , Diastolic Blood Pressure &gt; = 90 mm Hg . 3 . Proteinuria &gt; = 500 mg/day 4 . Worsening GFR ( &gt; 0.3 mg/dl 48 hr &gt; 50 % decline baseline Creatinine 1 week ) 1 . Allergy Larginine 2 . Systolic Blood Pressure &lt; 140 mm Hg , Diastolic Blood Pressure &lt; 90 mm Hg 3 . Proteinuria &lt; 500 mg/day 4 . Continuous tube feed ( since medication give inbetween meal )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hypertensive disease</keyword>
	<keyword>Renal failure</keyword>
	<keyword>High blood pressure</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>L-Arginine</keyword>
	<keyword>Placebo</keyword>
	<keyword>Phone call</keyword>
</DOC>